A clinical trial to investigate the efficiency of rosuvastatin in acute cardiomyopathy induced anthracycline
Phase 3
Recruiting
- Conditions
- Cardiomyopathy.Cardiomyopathy
- Registration Number
- IRCT2016121213090N3
- Lead Sponsor
- Vice chancellor for research of Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Cancerous patients undergoing treatment with anthracycline
Exclusion criteria: Patients with history of myocardial infarction; coronary artery disease; patients in the early stages of chemotherapy or radiotherapy; acute restraint or dilated cardiomyopathy; mitral and aortic valvular diseases in initial echocardiography; patients with a history or any symptoms associated with heart failure; hypersensivity to rosuvastatin; active liver diseases; and impaired liver tests; pregnant and lactating women.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Triglycerides level. Timepoint: 0 and 6 month. Method of measurement: mg/dl.
- Secondary Outcome Measures
Name Time Method eft ventricle ejection fraction. Timepoint: percent. Method of measurement: echocardiography.